Cost-effectiveness analysis of biphasic insulin aspart versus insulin glargine in people with type 2 diabetes in China
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1443
https://www.valueinhealthjournal.com/article/S1098-3015(14)01494-6/fulltext
Title :
Cost-effectiveness analysis of biphasic insulin aspart versus insulin glargine in people with type 2 diabetes in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01494-6&doi=10.1016/j.jval.2014.03.1443
First page :
A247
Section Title :
Diabetes/Endocrine Disorders I
Open access? :
No
Section Order :
918